Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

Kevin J. Severson; Helen J.L. Cumsky; Caitlin M. Brumfiel; Monica C. Janeczek; Brenda F. Ginos; Heidi E. Kosiorek; Jake Besch-Stokes; Meera H. Patel; William G. Rule; David J. DiCaudo; Allison C. Rosenthal; Mark R. Pittelkow; Aaron R. Mangold

doi:10.1016/j.jaad.2021.01.053

Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

Kevin J. Severson, Helen J.L. Cumsky, Caitlin M. Brumfiel, Monica C. Janeczek, Brenda F. Ginos, Heidi E. Kosiorek, Jake Besch-Stokes, Meera H. Patel, William G. Rule, David J. DiCaudo, Allison C. Rosenthal, Mark R. Pittelkow, Aaron R. Mangold

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	969-971
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	85
Issue number	4
DOIs	https://doi.org/10.1016/j.jaad.2021.01.053
State	Published - Oct 2021

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2021.01.053

Cite this

Severson, K. J., Cumsky, H. J. L., Brumfiel, C. M., Janeczek, M. C., Ginos, B. F., Kosiorek, H. E., Besch-Stokes, J., Patel, M. H., Rule, W. G., DiCaudo, D. J., Rosenthal, A. C., Pittelkow, M. R., & Mangold, A. R. (2021). Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study. Journal of the American Academy of Dermatology, 85(4), 969-971. https://doi.org/10.1016/j.jaad.2021.01.053

Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides : A prospective, open-label study. / Severson, Kevin J.; Cumsky, Helen J.L.; Brumfiel, Caitlin M.; Janeczek, Monica C.; Ginos, Brenda F.; Kosiorek, Heidi E.; Besch-Stokes, Jake; Patel, Meera H.; Rule, William G.; DiCaudo, David J.; Rosenthal, Allison C.; Pittelkow, Mark R.; Mangold, Aaron R.

In: Journal of the American Academy of Dermatology, Vol. 85, No. 4, 10.2021, p. 969-971.

Research output: Contribution to journal › Article › peer-review

Severson, KJ, Cumsky, HJL, Brumfiel, CM, Janeczek, MC, Ginos, BF, Kosiorek, HE, Besch-Stokes, J, Patel, MH, Rule, WG, DiCaudo, DJ, Rosenthal, AC, Pittelkow, MR & Mangold, AR 2021, 'Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study', Journal of the American Academy of Dermatology, vol. 85, no. 4, pp. 969-971. https://doi.org/10.1016/j.jaad.2021.01.053

Severson, Kevin J. ; Cumsky, Helen J.L. ; Brumfiel, Caitlin M. ; Janeczek, Monica C. ; Ginos, Brenda F. ; Kosiorek, Heidi E. ; Besch-Stokes, Jake ; Patel, Meera H. ; Rule, William G. ; DiCaudo, David J. ; Rosenthal, Allison C. ; Pittelkow, Mark R. ; Mangold, Aaron R. / Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides : A prospective, open-label study. In: Journal of the American Academy of Dermatology. 2021 ; Vol. 85, No. 4. pp. 969-971.

@article{f471d04baa8c462a9bbed924f94490a1,

title = "Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study",

author = "Severson, {Kevin J.} and Cumsky, {Helen J.L.} and Brumfiel, {Caitlin M.} and Janeczek, {Monica C.} and Ginos, {Brenda F.} and Kosiorek, {Heidi E.} and Jake Besch-Stokes and Patel, {Meera H.} and Rule, {William G.} and DiCaudo, {David J.} and Rosenthal, {Allison C.} and Pittelkow, {Mark R.} and Mangold, {Aaron R.}",

note = "Funding Information: Funding sources: Sun Pharmaceutical Industries Ltd., and The Kemper and Ethel Marley Foundation.Dr Mangold is an investigator for multiple studies in mycosis fungoides sponsored by Solagenix, MiRagen, Sun Pharma, and Elorac, and also serves on an advisory board for Kirin. Authors Severson, Brumfiel, Ginos, Kosiorek, Besch-Stokes, and Patel, and Drs Cumsky, Janeczek, Rule, DiCaudo, Rosenthal, and Pittelkow have no conflicts of interest to declare.",

year = "2021",

month = oct,

doi = "10.1016/j.jaad.2021.01.053",

language = "English (US)",

volume = "85",

pages = "969--971",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "4",

}

TY - JOUR

T1 - Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides

T2 - A prospective, open-label study

AU - Severson, Kevin J.

AU - Cumsky, Helen J.L.

AU - Brumfiel, Caitlin M.

AU - Janeczek, Monica C.

AU - Ginos, Brenda F.

AU - Kosiorek, Heidi E.

AU - Besch-Stokes, Jake

AU - Patel, Meera H.

AU - Rule, William G.

AU - DiCaudo, David J.

AU - Rosenthal, Allison C.

AU - Pittelkow, Mark R.

AU - Mangold, Aaron R.

N1 - Funding Information: Funding sources: Sun Pharmaceutical Industries Ltd., and The Kemper and Ethel Marley Foundation.Dr Mangold is an investigator for multiple studies in mycosis fungoides sponsored by Solagenix, MiRagen, Sun Pharma, and Elorac, and also serves on an advisory board for Kirin. Authors Severson, Brumfiel, Ginos, Kosiorek, Besch-Stokes, and Patel, and Drs Cumsky, Janeczek, Rule, DiCaudo, Rosenthal, and Pittelkow have no conflicts of interest to declare.

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85104398344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104398344&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2021.01.053

DO - 10.1016/j.jaad.2021.01.053

M3 - Article

C2 - 33493572

AN - SCOPUS:85104398344

VL - 85

SP - 969

EP - 971

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -

Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this